Participants
| Role | Name | HCID | Charge |
|---|
| Reactant | Tyramine | HCID 5610 | — |
| Reactant | Dimethylformamide | HCID 6228 | — |
| Reactant | Diisopropylethylamine | HCID 81531 | — |
| Reactant | 2,4-Dichloro-6-{[3-(4-fluorophenyl)propyl]methylamino}-1,3,5-triazine | HCID 11001562 | — |
| Reactant | 4-Fluoro-N-methyl-benzenepropanamine | HCID 11084266 | — |
| Product | HCID 11045887 | HCID 11045887 | 100% |
Reaction Steps
A solution of tyramine (302 mg, 2.3 mmol) and DIEA (299 mg, 2.3 mmol) in DMF (5 mL) was added dropwise to a DMF solution (5 mL) of 2,4-dichloro-6-{[3-(4-fluorophenyl)propyl]methylamino}-1,3,5-triazine (prepared in 92% yield via the procedure outlined for the preparation of Intermediate 13, using N-[3-(4-fluorophenyl)propyl]-N-methylamine, Intermediate 5), (714 mg, 2.3 mmol) in DMF (10 mL). The resulting solution was stirred at RT for 2 h. The solvent was removed under reduced pressure and the resulting residue was diluted with EtOAc (80 mL) and washed with 10% aqueous citric acid (2×40 mL). The organic layer was dried over sodium sulfate and concentrated to give the title compound (950 mg, 100%) as a white solid which was used without further purification: 1H NMR (CDCl3, 400 MHz) δ 7.27-6.94 (m, 6H), 6.75 (m, 2H), 5.40-5.32 (d, br, 1H) 3.72-3.56 (m, 4H), 3.11 (m, 3H), 2.78 (m, 2H), 2.62 (m, 2H), 1.92 (m, 2H); Low resolution MS (ES+) m/e 416.4 (MH+). Intermediate 22: tert-butyl 4-(4-{[3-(4-chlorophenyl)propyl]sulfanyl}-6-{[2-(4-hydroxyphenyl)ethyl]amino}-1,3,5-triazin-2-yl)-1-piperazinecarboxylate
Provenance & Evidence
| DOI | 10.6084/m9.figshare.5104873.v1 |
|---|
| Patent number | US06943162B2 |
|---|
| Source dataset | uspto-grants-2005_09 |
|---|
| ORD ID | ord-9ce16c11dfac481a8c875b89f2d874c4 |
|---|
| Source note | uspto-grants-2005_09 |
|---|